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Region Critical for ATP-Sensing of the KATP Channel
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Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110
ABSTRACT ATP-sensitive K1-channels link metabolism and excitability in neurons, myocytes, and pancreatic islets. Mutations
in the pore-forming subunit (Kir6.2; KCNJ11) cause neonatal diabetes, developmental delay, and epilepsy by decreasing
sensitivity to ATP inhibition and suppressing electrical activity. Mutations of residue G53 underlie both mild (G53R,S) and severe
(G53D) forms of the disease. All examined substitutions (G53D,R,S,A,C,F) reduced ATP-sensitivity, indicating an intolerance of
any amino acid other than glycine. Surprisingly, each mutation reduces ATP afﬁnity, rather than intrinsic gating, although structural
modeling places G53 at a signiﬁcant distance from the ATP-binding pocket. We propose that glycine is required in this location
for ﬂexibility of the distal N-terminus, and for an induced ﬁt of ATP at the binding site. Consistent with this hypothesis, glycine
substitution of the adjacent residue (Q52G) partially rescues ATP afﬁnity of reconstituted Q52G/G53D channels. The results
reveal an important feature of the noncanonical ATP-sensing mechanism of KATP channels.
INTRODUCTION
The ATP-sensitive K1-channel (KATP) controls cellular
function in neurons, b-cells, and other tissues by translating
changes in cellular metabolism (represented by the [ATP]/
[ADP] ratio) into changes in electrical activity. Aberrantly
elevated KATP activity is predicted to decrease excitability,
and thereby compromise cell function. An increase in KATP
activity in the pancreatic b-cell impairs insulin release at
stimulatory blood-glucose concentrations (1–3). In addition,
channel overactivity in the central nervous system is pre-
dicted to underlie seizure events (4–7), and it appears that
ketogenic diets may actually protect against seizure by en-
hancing the damping effect of KATP channels on electrical
activity (8). Activating mutations in KATP (both the Kir6.2
(KCNJ11) and SUR1 (ABCC8) subunits) represent a com-
mon cause of neonatal diabetes mellitus (NDM) in humans, a
disease characterized as an insulin-dependent hyperglycemia
diagnosed before 6 months of age (9). The diabetes may be
either permanent (PNDM) or transient (TNDM) in form
(10,11). In the most severe cases, KATP mutations are asso-
ciated with neurological features that include developmental
delay (both motor and intellectual), epilepsy, and neonatal
diabetes (referred to as DEND syndrome) (12), and these
extrapancreatic symptoms likely reﬂect KATP overactivity
in muscle, peripheral neurons, and/or brain. Importantly,
sulfonylureas, which speciﬁcally block the KATP channel,
can reverse the diabetes and ameliorate the associated neu-
rological features (6,13,14).
Structurally, the KATP channel is a hetero-octomer com-
prised of four pore-forming Kir6.2 subunits bordered by four
regulatory SUR1 subunits. Whereas SUR1 confers sensitiv-
ity of the channel to stimulatory MgADP and the inhibitory
sulfonylureas, the Kir6.2 subunit confers the characteristic
ATP-inhibition of the channel. The predicted ATP-binding
pocket in Kir6.2 is formed by residues located in both the
cytoplasmic N- and C-termini such that each Kir6.2 subunit
in the tetramer is capable of binding a molecule of ATP, and
binding of ATP to one subunit is sufﬁcient to cause channel
closure (15,16).
To date, more than 40 heterozygous activating mutations
in Kir6.2 (KCNJ11) have been reported worldwide and
shown to be variably associated with both the transient and
permanent forms of the disease (17–19). Without exception,
these diabetes-causing mutations activate KATP by increasing
the half-inhibitory ATP concentration (K1/2,ATP) (20–24).
Mechanistically, these mutations decrease ATP-sensitivity
either 1), by directly decreasing ATP-binding to Kir6.2
(e.g., R50P), or 2), by altering intrinsic channel-gating (i.e.,
increasing open probability in the absence of ATP (po,zero),
e.g., Q52R). In the latter case, ATP-sensitivity is reduced
allosterically, because ATP predominantly interacts with
closed states of the channel, to which access is reduced when
the open state is favored (25,26).
Recently we described the phenotype and therapy of
an adult patient with intermediate DEND (developmental
delay and neonatal diabetes, but not epilepsy) attributable to
the G53D mutation in KCNJ11 (14). Functional analysis
of reconstituted G53D channels (Kir6.2[G53D] 1 SUR1)
demonstrated a signiﬁcant rightward shift in the ATP dose-
response curve. Consistent with channel overactivity in the
cellular environment, whole-cell KATP currents were signif-
icantly increased in transfected mammalian cells expressing
G53D channels, compared with the wild-type (WT) (14).
Here, we characterize the effects of mutations in this region in
greater detail. Although G53 resides outside the predicted
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ATP-binding pocket, theG53Dmutation alters ATP-sensitivity
without altering the intrinsic gating behavior of the channel
(as reﬂected by the po,zero and kinetic behavior of single
channels). This contrasts sharply with all other reported non-
ATP-binding mutations that indirectly alter ATP-sensitivity
by changing gating kinetics (20,21,24). Furthermore, we
show that the G53 position is highly intolerant of amino-acid
substitutions with respect to ATP-sensitivity, but the loss
of ATP-sensitivity can be partially rescued by glycine sub-
stitution at the adjacent residue (Q52G). These results dem-
onstrate that ﬂexibility of this N-terminus region is necessary
for efﬁcient ATP binding, and this leads us to speculate that
the rotational ﬂexibility of G53 constitutes an interfacial gat-
ing hinge, separate from the gate involved in ion conduction,
which allows for movement of the N-terminal region and an
induced ﬁt of ATP at its binding pocket.
METHODS
Molecular biology
We cloned Kir6.2 into the EcoRI/ClaI sites of pCMV6b and the parental
plasmid DNAwas used to generate Kir6.2 mutations using the QuickChange
Site Directed Mutagenesis Kit (Stratagene, La Jolla, CA). The SUR1 was
cloned into the pECE expression vector. The nucleotide sequences of mutant
Kir6.2 constructs were veriﬁed by ﬂuorescence-based cycle sequencing,
using AmpliTaq DNA polymerase, FS (Perkin-Elmer, Foster City, CA), and
an ABI Prism DNA sequencer (Perkin-Elmer).
Expression of KATP channels in COSm6 cells
COSm6 cells were plated at a density of ;2.5 3 105 cells per well (30-mm
six-well dishes) and cultured in Dulbecco’s modiﬁed Eagle’s medium plus
10 mM glucose (DMEM-HG), supplemented with fetal calf serum (FCS,
10%). The COSm6 cells were transfected with cDNA using FuGENE 6
Transfection Reagent (Roche Diagnostics, Indianapolis, IN). Total DNA
(0.3 mg Kir6.2 (27) plus 0.5 mg SUR1 (28) plus 0.3 mg green ﬂuorescent
protein as a marker for transfection) was mixed with FuGENE 6 and pre-
incubated for 1 h. Cells were incubated in the presence of the transfection
mixture for 12–24 h, and plated on sterile glass coverslips overnight before
patch-clamp experiments.
Electrophysiological methods
Patch-clamp experiments were performed at room temperature in an oil-gate
chamber that allowed the solution bathing the exposed surface of the isolated
patch to be changed rapidly. The COSm6 cells that ﬂuoresced green under
ultraviolet illumination were selected for patch-clamping 3–5 days after
transfection. Membrane patches were voltage-clamped using a CV-4 head
stage, an Axopatch 1-D ampliﬁer, a Digidata 1322A digitizer board (all from
Axon Instruments, Union City, CA), and an MP-225 micromanipulator
(Sutter Instrument, Novato, CA). All currents were measured at a membrane
potential of 50 mV (pipette voltage, 150 mV). Data were collected using
the pClamp 8.2 software suite (Axon Instruments) and Microsoft Excel
(Microsoft, Redmond, WA). Bath and pipette control solutions (KINT)
contained 150 mM KCl, 10 mM HEPES, and 1 mM EGTA, pH 7.4. Where
indicated, ATP was added to the bathing solution as dipotassium salts.
Phosphotidyinositol-4,5-bisphosphate (PIP2; Avanti Polar Lipids, Alabaster,
AL) was dissolved in KINT to a stock concentration of 1 mg/mL, and diluted
to a working concentration of 5 mg/mL.
Data analysis
Quantitative analysis of ATP inhibition
The ATP dose-response was quantiﬁed by ﬁtting the raw data with a Hill
equation:
Irel ¼ 1=ð11 ð½ATP=K1=2;ATPÞHÞ; (1)
where Irel is the current relative to that in the absence of ATP, [ATP] is the
ATP concentration, K1/2,ATP is the half-maximal inhibitory ATP concentra-
tion, and H is the Hill coefﬁcient, which was ﬁxed at 1.3.
Single-channel analysis
Unconditional mean lifetimes in the open and closed states were determined
from idealized (using pClamp 8.2 software) records of channel activity from
patches containing 1–4 channels.
Estimation of po,zero
Two approaches were used to estimate po,zero, the initial open probability (in
zero ATP), after the excision of isolated membrane patches containing
multiple channels. In method I, PIP2 was added to the patch until the current
reached a saturating level (IPIP2). This was assumed to represent a maximum
po,zero of ;0.97 (26). The fold increase in current was calculated (fold in-
crease ¼ Iinitial/IPIP2; see Fig. 2), and po,zero was estimated from:
po;zero ¼ 0:97=ðfold increaseÞ: (2)
Method II involved noise analysis (NA). Mean po,zero was estimated from
stationary ﬂuctuation analysis of macroscopic currents (29,30) on short
(,1 s) recordings of currents in zero [ATP] and in 5 mM [ATP]. Currents
(4 pA , mean current , 4 nA, at 50 mV, corresponding to ;1–1000
channels) were ﬁltered at 1 kHz and digitized at 3 kHz, with 12-bit resolution.
Mean patch current (I) and variance (a2) in the absence of ATPwere obtained
by subtraction of the mean current and variance in 5 mMATP (i.e., assuming
all channels were closed), respectively. Single-channel current (i) was as-
sumed to be 3.75 pA, corresponding to a WT single-channel conductance
of 75 pS. The po,zero was then estimated according to
po;zero ¼ 1 ða2=½i3 IÞ: (3)
Model simulation of po,zero versus
K1/2,ATP relationship
Although complex models of KATP gating can describe essentially all of the
gating behavior of the channel (16,31,32), a simpliﬁed four-state model
quantitatively describes channel behavior over a wide range of conditions,
including changing levels of ATP and PIP2, as well all mutational effects on
ATP afﬁnity (KD) or the intrinsic open-closed equilibrium (KCO) (model II of







In this kinetic scheme, C represents the ATP-dependent closed state, Cin
the ATP-independent closed state, CF the fast closed state, and O the open
state. KD is the dissociation constant for the ATP-binding step, and KCO is the
equilibrium constant for the open-to-closed (Cin) transition. The key feature
of thismodel is thatATP acts by binding to a closed state and, in consequence,
the apparentATP-sensitivity can be reduced either by shifting the equilibrium
between the Cin and O states toward the open state (increasing KCO), or by
reducing ATP-binding (increasing KD). Model simulations were generated
using Microsoft Excel.
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Calculations of free energy for ATP-binding
The free energy of ATP-binding was calculated for individual membrane
patches using
DG ¼ 2:303RT log10 ½KD; (4)
where R is the gas constant (1.983 103 kcal mol1deg1), T is the absolute
temperature (298 K), and KD is the dissociation constant for ATP in the
above model. For mutant KATP channels (G53D, Q52G, and G53D/Q52G),
the free-energy effect of the mutation (DDG) was obtained by subtracting the
averaged value of DG for wild-type channels (see Fig. 6 F).
RESULTS
Molecular model of Kir6.2 and location of G53
Structural modeling of the Kir6.2 tetrameric pore places the
G53 residue distal to the ATP-binding pocket and adjacent to
the slide helix, which previously has been implicated in Kir
channel gating (Fig. 1, A and B) (15,33). Mutations of nearby
residues Q52 and V59 (Q52R and V59M) also underlie
NDM, and were shown to reduce ATP-sensitivity indirectly
by increasing the open probability of the channel (20,21).
Just distal to G53 in the primary sequence is residue R50,
which forms part of the binding pocket and is predicted
to interact electrostatically with the g-phosphate of ATP.
Consistent with this role, the diabetes-causing R50P muta-
tion signiﬁcantly reduces the ATP-sensing of reconstituted
channels, but without altering intrinsic gating behavior (34).
Intolerance of KATP to amino-acid substitutions
at the G53 residue
Coexpression of WT Kir6.2 and SUR1 in COSm6 cells
generates KATP channels that are inhibited by ATP in excised
patch-clamp experiments, with an ATP-sensitivity similar to
that of native channels (K1/2,ATP ¼ ;10 mM; Fig. 2) (27).
Conversely, homomeric mutant channels containing substi-
tutions at residue G53 (Kir6.2[G53x] 1 SUR1) all exhibit
a signiﬁcant decrease in ATP-sensitivity relative to WT:
K1/2,ATP ¼ 190 mM (G53D), 124 mM (G53F), 87 mM
(G53S), 66mM (G53A), 62mM (G53C), and 52mM (G53R).
The G53R and G53S mutations underlie several cases of
FIGURE 1 Location of G53 in predicted Kir6.2 structure. (A) Ribbon
diagram of two of four Kir6.2 subunits that form K1-selective pore in KATP.
Dashed box corresponds to region that was magniﬁed to create B. (B)
Residues (highlighted) in Kir6.2 that are mutated in neonatal diabetes.
Residues are classiﬁed as those that form part of the ATP-binding pocket
(red), or are involved in channel-gating, and therefore indirectly in ATP-
sensitivity (green). The G53 residue that neither forms part of the
ATP-binding pocket nor alters gating behavior when mutated is shown in
orange. The bound ATP molecule is shown in yellow, and the interfacial
slide-helix region is shown as a-helical. (C) Conformational angles around
a-carbons in amino-acid backbone of Kir6.2 are shown in a Ramachandran
plot (c versus f). Bond angles associated with a-helical and b-sheet
structures are indicated. Glycine residues are shown as open symbols, and all
other residues are shown as solid symbols. Ramachandran data analysis was
performed using Visual Molecular Dynamics software (http://www.ks.uiuc.
edu/Research/vmd/).
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TNDM, and functional analyses of these mutants expressed
in Xenopus oocytes demonstrated similar shifts in ATP-
sensitivities (23).
Unaltered open probability in G53
mutated channels
Two approaches were used to estimate open probability in the
absence of inhibitory ATP (po,zero) in macroscopic record-
ings: nonstationary NA (method II) (29), and the application
of PIP2 (method I) (20)(see Methods). Both methods gave
similar values for po,zero for both WT and G53D mutant
channels (Fig. 3; po,zero¼ 0.47 (WT) and 0.49 (G53D),
averages from both methods I and II). Similarly, the TNDM-
causing G53R mutation did not signiﬁcantly affect po,zero
(0.57), although the G53S mutation did slightly increase
open probability relative toWT (po,zero¼ 0.67). This increase
in po,zero was statistically signiﬁcant by the NA method,
but did not reach signiﬁcance using the PIP2 method. By
comparison, the diabetes-linked Glu to Arg mutation at the
adjacent residue 52 (Q52R) signiﬁcantly increased the open
probability (po,zero ¼ ;0.9), and this gating effect can fully
account for the reported decrease in ATP-sensitivity of Q52R
channels (20,21).
Altered relationship between ATP-sensitivity and
open probability in G53D channels
As described above, multiple studies of channel-gating
demonstrated a nonlinear relationship between po,zero and
K1/2, ATP (26,35,36). Wild-type channels have an intrinsic po
of ;0.5, and an intrinsic K1/2,ATP of ;10 mM (Fig. 4, A and
C). Application of PIP2 leads to a gradual increase in po,zero
and K1/2,ATP, in accordance with the prediction of the model
(solid lines in Fig. 4 C indicate the prediction of the inset
model with parameters from model II of Enkvetchakul et al.
(26), with KD ¼ 5.8 mM). The gating mutant Q52R has a
much higher intrinsic po,zero (;0.9) and K1/2 ATP (;125mM),
reﬂecting a higher intrinsic KCO, but the response to PIP2
follows the same relationship, reﬂecting no change in ATP
afﬁnity (KD). The model predicts that a Kir6.2 mutation that
alters ATP binding alone will be shifted to a different rela-
tionship, with a higher K1/2,ATP for any given po,zero. This is
the case for the G53D channels (Fig.4 C, upper solid line). At
similar open probabilities, a higher K1/2 ATP was measured
for G53D channels compared with WT, corresponding to a
KD value of 72 mM (i.e., ;13-fold lower than WT). The
ﬁnding that G53 mutations affect ATP afﬁnity, but not in-
trinsic gating, is initially surprising, given that G53 is located
outside the ATP-binding pocket (Fig. 1).
Unaltered gating behavior in G53D channels
To examine the gating kinetics of G53D channels in detail,
single-channel currents were recorded from cells expressing
WT or mutant KATP channels (Fig. 5). Consistent with the
macroscopic analysis of channel open probability, there was
no signiﬁcant difference in po,zero values between WT and
FIGURE 3 Unaltered maximum open probabilities of reconstituted KATP
channels containing G53 mutations. Open probability in absence of ATP
(po,zero) was calculated from individual membrane patches expressing
reconstituted wild-type and G53x mutant channels. Method I used PIP2
stimulation to estimate po,zero, and method II used nonstationary noise
analysis (NA; see Methods). For comparison, the po,zero of the gating
mutation, Q52R, is also shown (20). Data points represent mean6 SE (n ¼
5–17 patches, method I; n¼ 10–27 patches, method II). *p, 0.05 and **p,
0.01 compared with WT by unpaired Student’s t-test.
FIGURE 2 Reduced ATP-sensitivity
of reconstituted KATP channels contain-
ing G53 mutant subunits. Representative
currents were recorded from inside-out
membrane patches from COS cells ex-
pressing (A) wild-type (Kir6.2(WT) 1
SUR1) or (B) mutant (Kir6.2(G53D) 1
SUR1) KATP channels at50 mV in Kint
solution (see Methods). Patches were
exposed to differing [ATP], and baseline
current was determined by exposure to
ATP (5 mM). (C) Steady-state depen-
dence of membrane current on [ATP] (relative to current in zero ATP (Irel)) for wild-type and G53X-containing channels. K1/2,ATP ¼ 10 mM (WT), 190 mM
(G53D), 124mM (G53F), 87mM (G53S), 66mM (G53A), 62mM (G53C), and 52mM (G53R). Data points represent mean6 SE (n¼ 4–30 patches). Fitted lines
correspond to least-squares ﬁts of a Hill equation (see Methods).
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G53D single channels, although the estimated open proba-
bilities were lower than those calculated using the indirect
methods (Table 1). The gating behavior was also not different
between WT and G53D channels with groups of openings
being clustered in similarly timed bursts in both channels
(Fig. 5), and both channels displayed similar mean open
(topen) and closed times (tclosed), as well as single-channel
current (Table 1). By contrast the disease-causing Q52R
mutation predictably displayed an increase in po,zero in single
channels with a signiﬁcantly lower mean closed time (Fig. 5,
Table 1). Together with the macroscopic analysis, these data
strongly support the conclusion that gating behavior is not
altered in G53D channels.
Ramachandran plot of Kir6.2
The intolerance for amino-acid substitutions at the G53 po-
sition with respect to ATP-sensitivity (Fig. 2) implies the
importance of rotational ﬂexibility at this position. The f and
c torsion angles around the a-carbons in the Kir6.2 model
(15) were analyzed in a Ramachandran plot (37) (Fig. 1 C).
Glycine has no side chain, and therefore can adopt f and c
angles in all four quadrants, and frequently occurs in regions
of proteins where any other residue would be sterically hin-
dered. Indeed, in the Ramachandran plot of the modeled
Kir6.2 structure, the G53 residue is found in the lower right
quadrant, occupied primarily by glycines and very few other
amino acids (Fig. 1 C).
Importance of rotational ﬂexibility at the G53
position for ATP-sensing of the channel
As detailed in the Discussion, we propose that residue G53
uniquely controls ATP-binding through a long-range action
on the proximal N-terminus. Speciﬁcally, we suggest that
G53 acts as a hinge to allow a rigid body movement of
the distal N-terminus that is necessary to fully accommodate
ATP at its binding pocket (38). The existence of a hinge
FIGURE 4 PIP2 stimulation of wild-type and mutant
(G53D) KATP channels. Representative currents were
recorded from membrane patches containing either (A)
wild-type (Kir6.2(WT) 1 SUR1) or (B) mutant
(Kir6.2[G53D] 1 SUR1) KATP channels at 50 mV.
Bars indicate application of PIP2 (5mg/mL) or different
[ATP] (as shown). Lower dashed line indicates zero
current. Insets: Expanded records from ﬁrst 50–100 s
after patch excision, from which ATP-sensitivity and
open probability (NA method) were estimated. (C)
Relationship between po,zero and K1/2, ATP (mM). Solid
lines represent modeled data calculated from model II
of Enkvetchakul et al. (26). Symbols represent data
points calculated from individual membrane patches:
WT (Kir6.2(WT) 1 SUR1), G53D (Kir6.2(G53D) 1
SUR1), or Q52R (Kir6.2(Q52R) 1 SUR1). Modeled
data were ﬁt using nonlinear regression analysis.
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would explain the speciﬁc requirement for a glycine at this 53
position, but may also suggest that the hinge could be placed
at an adjacent residue, to overcome the detrimental effect of
substitutions at residue 53.
As shown in Fig. 6, A–C, the Q52G mutation
(Kir6.2[Q52G] 1 SUR1) has no signiﬁcant effect on ATP-
sensitivity or on open probability, compared with the WT
channel (Kir6.2WT] 1 SUR1). However, on the G53D back-
ground, the double-mutant channel (Kir6.2[Q52G,G53D] 1
SUR1) exhibits a signiﬁcant left shift in ATP-sensitivity, com-
pared with G53D channels alone (K1/2,ATP ¼ 16.4 6 1.7
mM (WT), 22.7 6 3 mM (Q52G), 64.9 6 6.1 mM (Q52G/
G53D), and 226 6 21.2 mM (G53D)). This shift in ATP-
sensitivity corresponds to a considerably smaller increase
in the free energy of ATP binding (DDG ¼ 0.99 kcal mol1)
for the combined mutant channel than is predicted from
the additive effect of each mutant alone (DDG[Q52G] 1
DDG[Q52G/G53D] ¼ 1.79 kcal mol1) (Fig. 6 D; see
Methods). Although po,zero is unaffected by either the Q52G or
G53D single mutations, the Q52G/G53D double-mutant
channel exhibits a small decrease in open probability that
reached signiﬁcance using the NA method (method II) (Fig.
6 F). Given the coupled relationship between po,zero and
K1/2,ATP (Fig. 4), the possibility exists that the decrease inATP-
sensitivity observed for the combined Q52G/G53D mutant
channels is simply a consequence of the reduced open proba-
bility. However, when the po,zero and K1/2,ATP relationship for
the Q52G/G53D mutant is modeled as above (Fig. 4), the ﬁt
data reside on a different curve than that of the G53D channels
alone (Fig. 6 E) (Kruskal-Wallis test, p, 0.01). This indicates
that the decrease in open probability alone is insufﬁcient to
account for the observed shift in ATP-sensitivity of the double-
mutant channel, and that Q52G can partly restore ATP afﬁnity
on the G53D background. Taken together, the data strongly
implicate rotational ﬂexibility in the immediate G53 region as
necessary for high ATP afﬁnity.
DISCUSSION
KATP channel overactivity and disease severity
Previous studies demonstrated that distinct mutations of the
G53 residue in Kir6.2 (G53S, G53R, and G53D) decrease
ATP-sensitivity and underlie NDM or DEND (14,23). In
the current study, a direct comparison indicates that the ATP-
sensitivity of DEND-causing G53D channels is decreased
;20-fold, compared with a ;5–9-fold decrease for both the
TNDM-associated G53S and G53R mutations. Because the
relative ATP-sensitivity of the channel is an accurate pre-
dictor of KATP activity in vivo, these data are consistent with
a genotype-phenotype relationship in which greater over-
activity of KATP causes a more severe disease phenotype.
Only with the most severe activating mutations (e.g., G53D)
is overactivity associated with both diabetic and neurolog-
ical symptoms, indicating that extrapancreatic tissues (e.g.,
muscle, nerve, and brain) are less sensitive to changes in
FIGURE 5 Unaltered gating behavior in single G53D channels. Repre-
sentative single-channel currents were recorded at 50 mV from inside-out
membrane patches excised from COS cells expressing either WT (Kir6.21
SUR1), G53D (Kir6.2[G53D]1 SUR1), or Q52R (Kir6.2[Q52R]1 SUR1)
channels. Two different timescales (2 s and 0.1 s) are shown for currents
from each channel.
TABLE 1 Single-channel properties of wild-type and mutant
Kir6.2 1 SUR1 channels
Construct i (nA) topen (ms) tclosed (ms) po,zero n
WT 3.59 6 0.2 3.5 6 0.4 24.4 6 5.4 0.145 6 0.034 4
G53D 3.43 6 0.1 3.4 6 0.6 23.7 6 8.1 0.198 6 0.125 4
Q52R 3.58 6 0.02 3.4 6 0.5 0.9 6 0.2* 0.796 6 0.037* 3
i, single-channel current; topen and tclosed, are unconditional mean open and
closed times, determined from idealized records from n patches, each
containing 1–4 active channels (mean number of channels per patch of
2.75, 2.5, and 1 for WT, G53D, and Q52R, respectively). po,zero ¼ topen/
(topen 1 tclosed).
*Signiﬁcantly different from WT (p , 0.001).
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KATP activity than the pancreatic b-cell, and that a threshold
of channel overactivity must be reached before neurological
features become evident.
Mechanistic basis of G53D-associated diabetes
Homology modeling and ligand-docking analyses of Kir6.2
led to a detailed structural view of the ATP-binding site
formed by residues in the N-termini and C-termini of Kir6.2
(Fig. 1) (15). In support of the model, residues that comprise
the ATP-binding pocket decrease ATP-sensitivity when
mutated, but without altering open probability. Consistently,
residues located in regions outside the ATP-binding pocket
decrease ATP-sensitivity when mutated, but do so indirectly
through an increase in po,zero. The G53 residue is located at
the N-terminal end of the slide helix of Kir6.2, and at a
predicted distance of ;13 A˚ from the bound molecule of
ATP (Fig. 1). Immediately adjacent to G53 in the primary
structure (and located between G53 and the bound ATP
molecule) is Q52, which when mutated to arginine also
causes NDM (Q52R) (13). However, in this case, the Q52R
mutation clearly reduces ATP-sensitivity indirectly through
an increase in the intrinsic open probability (20). Both non-
stationary NA and PIP2 estimates demonstrate that po,zero
does not differ signiﬁcantly between WT and G53 channels.
Thus, the effect of the G53D mutation on ATP-sensitivity is
clearly on ATP afﬁnity, yet the residue is not physically part
of the ATP binding site.
Recent molecular modeling, together with functional
studies, supports a putative structure of the PIP2 binding site
FIGURE 6 ATP afﬁnity is partially
restored in Q52G/G53D double-mutant
channels. (A) Representative currents
recorded from inside-out membrane
patches from COS cells expressing
WT, G53D, Q52G, or Q52G/G53D
channels. Patches were exposed to var-
ious [ATP], as indicated. (B) Steady-
state dependence of membrane current
on [ATP] (relative to current in zero
ATP (Irel)) for wild-type and G53x mu-
tant channels. Data points represent
mean 6 SE (n ¼ 10–30 patches). Fitted
lines correspond to least-squares ﬁts of a
Hill equation (see Methods). (C) Aver-
age of K1/2,ATP values from individual
patches, calculated using Hill equation:
**p, 0.01 by unpaired Student’s t-test.
(F) Maximum open probability in ab-
sence of ATP (po,zero) was calculated
from individual membrane patches, as
in Fig. 3. Data points represent mean 6
SE (n ¼ 9–17 patches, method I; n ¼ 9–
24 patches, method II). *p , 0.05 by
unpaired Student’s t-test, compared with
WT and G53D channels. (E) Relation-
ship between po,zero and K1/2,ATP (mM).
Solid lines represent modeled data cal-
culated from model II of Enkvetchakul
et al. (26). Symbols represent data points
calculated from individual membrane
patches. Modeled data were ﬁt using
nonlinear regression analysis. For statisti-
cal analysis, the Kruskal-Wallis test was
performed on equilibrium constants for
ATP-binding (KD derived from model
ﬁts,Eq. 3) from individual patches shown:
Q52G/G53DversusG53D,p, 0.01;WT
versus Q52G/G53D, p, 0.001; and WT
versus G53D, p, 0.001. (D) Free energy
of ATP binding for mutant KATP chan-
nels. The Gibbs free energy (DG(kJ
mole1)) was calculated from Eq. 3 for individual patches, using the ﬁtted dissociation constant (KD) (see Methods). To calculate DDG (kcal mole
1)
values for mutant channels, the averaged free energy value from WT channels was subtracted from the averaged values for mutant KATP channels. Diamonds
represent predicted DDG (kcal mole1) value for combined mutant channel (DDG[G53D] 1 DDG[G53D/Q52G]), assuming an additive effect. Data points
represent mean 6 SE (n ¼ 9–37 patches).
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on Kir6.2 that includes several residues in the slide helix
region of the protein (38–41). Of these, R54 is predicted to
interact electrostatically with the negative charges of the
anionic headgroup of PIP2. Therefore, given the close
proximity of the slide helix region to the PIP2 binding site,
mutating Q52 to a positively charged arginine might elec-
trostatically increase the binding afﬁnity of PIP2, which could
then underlie the observed increase in po,zero, and the con-
current decrease in ATP-sensitivity of the reconstituted
channel. Consistent with this interpretation, replacing Q52
with an uncharged glycine residue is not predicted to alter
PIP2 binding, explaining the lack of effect of the Q52G
mutation itself on channel activity (Fig. 5).
Residue G53 as an interfacial gating hinge
Several lines of evidence support a requirement for rotational
ﬂexibility at residue G53 for normal ATP-sensing. First, all
amino-acid substitutions at G53 were poorly tolerated with
respect to ATP-sensitivity, including alanine, which has the
secondsimplest sidechain (CH3).Second, theRamachandran
plot of theKir6.2 structuralmodel reveals torsion angles around
the a-carbon of G53 that are not found in most other amino
acids in the structure. Third, introducing Q52G on the G53D
background, which is expected to restore ﬂexibility of the
region, results in a decrease in free energy of ATP-binding,
reﬂected in a leftward shift in the ATP-dose response curve.
Although theQ52G/G53D doublemutation decreases the open
probability of reconstituted channels, this alone cannot fully
account for the observed decrease in K1/2,ATP (Fig. 6).
Because the G53D mutation does not alter channel-gating,
a logical interpretation of this data is that rotational ﬂexibility
is required for 1), directly regulating access of ATP to its
binding pocket, 2), supporting a proper ﬁt after ATP is
bound, or 3), transducing the signal of ATP-binding to
channel closure. Modeled simulations of PIP2 binding to
Kir6.2 demonstrate that the ATP-binding residue, R50, re-
sides in a ﬂexible loop that acts as a ‘‘gate’’ for ATP-binding
(38). In the closed, locked position, R50 interacts electro-
statically with the g-phosphate of the bound ATP molecule.
However, with PIP2 stimulation, this ﬂexible region moves,
breaking the electrostatic interaction between the R50 residue
and ATP, and carrying R50 away from the binding pocket,
thereby decreasing ATP-binding afﬁnity. Given the close
connection of G53 to R50, and the observation that rotational
ﬂexibility is important at the G53 position, we speculate that
G53 may act as ‘‘gating hinge’’, separate from the gate to
ion conductance, necessary for ﬂexibility of the proximal
N-terminal region containing R50 (Fig. 7). Thus, any muta-
tions in G53 that restrict movement of the ‘‘hinge’’ would
decrease ATP-afﬁnity. The existence of a glycine ‘‘hinge’’
will, of course, require detailed structural information that is
not available in the current data set, in which we examined
only the functional consequences of G53 mutations. Never-
theless, it is interesting that the glycine at position 53 is also
found in the Kir6.1 channel, but is poorly conserved among
other Kir channels (42). This may not be unexpected, insofar
as Kir6.1 and Kir6.2 channels are the only members of the
Kir family that are regulated by nucleotide-binding directly to
the Kir subunit (43).
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